• Return to Headlines

Sarepta Therapeu Shares Up 24.3% Since SmarTrend's Buy Recommendation (SRPT)

By David Diaz

SmarTrend identified an Uptrend for Sarepta Therapeu (NASDAQ:SRPT) on April 11th, 2018 at $79.45. In approximately 2 months, Sarepta Therapeu has returned 24.31% as of today's recent price of $98.76.

Over the past year, Sarepta Therapeu has traded in a range of $30.09 to $100.30 and is now at $98.76, 228% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.8% while the 200-day MA has risen 1.5%.

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Sarepta Therapeu shares.

Log in and add Sarepta Therapeu (SRPT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights sarepta therapeu

Ticker(s): SRPT